Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|April 13, 2023
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19Lucrezia Laterza, Lorenza Putignani, Carlo Romano Settanni, et al.
Inflammatory Bowel Diseases|July 8, 2026
Timing of biologic prophylaxis and postoperative recurrence in Crohn's disease: A real-life cohort study using propensity score weightingAngelo Del Gaudio, Federica Di Vincenzo, Giuseppe Cuccia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 30, 2026
Vedolizumab for the prevention and treatment of postoperative recurrence in Crohn's disease: A real- world latium net studyAngelo Del Gaudio, Emma Calabrese, Paola Balestrieri, et al.
Journal of Crohn'S & Colitis|December 29, 2025
Inflammatory Bowel Disease is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activityValentina Petito, Daniela Gerovska, Antonia Piazzesi, et al.
Inflammatory Bowel Diseases|April 28, 2026
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory studyPierluigi Puca, Letizia Masi, Simone Parello, et al.
Nutrients|May 28, 2025
Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled TrialLucrezia Laterza, Cesare Cremon, Gaetano Coppola, et al.
Microorganisms|October 28, 2023
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian StudyLoris Riccardo Lopetuso, Lucrezia Laterza, Valentina Petito, et al.
United European Gastroenterology Journal|May 23, 2020
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centreFranco Scaldaferri, Daniela Pugliese, Giuseppe Privitera, et al.
Microorganisms|June 27, 2025
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up StudyFranco Scaldaferri, Antonio Maria D'Onofrio, Elena Chiera, et al.
BMJ Open Gastroenterology|May 5, 2026
Effectiveness and safety of mirikizumab in ulcerative colitis: real-world data from the Latium NetMarco Murgiano, Paola Balestrieri, Emma Calabrese, et al.
Pageof 8